Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-035909
Filing Date
2025-02-26
Accepted
2025-02-26 08:30:10
Documents
4
Period of Report
2025-02-26

Document Format Files

Seq Description Document Type Size
1 6-K d914050d6k.htm 6-K 8046
2 EX-99.1 d914050dex991.htm EX-99.1 131233
3 GRAPHIC g914050g0225233906509.jpg GRAPHIC 5422
4 GRAPHIC g914050g0225233907058.jpg GRAPHIC 3468
  Complete submission text file 0001193125-25-035909.txt   152911
Mailing Address 2015 PEEL STREET 5TH FLOOR MONTREAL A8 H3A 1T8
Business Address 2015 PEEL STREET 5TH FLOOR MONTREAL A8 H3A 1T8 514-336-7800
Theratechnologies Inc. (Filer) CIK: 0001512717 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1130
Type: 6-K | Act: 34 | File No.: 001-35203 | Film No.: 25666275
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)